BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Maconi G. Dermatological Manifestations in Inflammatory Bowel Diseases. J Clin Med 2021;10:364. [PMID: 33477990 DOI: 10.3390/jcm10020364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 He KJ, Dong JH, Ouyang XM, Huo YN, Cheng XS, Lin Y, Li Y, Gong G, Liu J, Ren JL, Guleng B. Glycerol monolaurate ameliorates DSS-induced acute colitis by inhibiting infiltration of Th17, neutrophils, macrophages and altering the gut microbiota. Front Nutr 2022;9:911315. [PMID: 36034889 DOI: 10.3389/fnut.2022.911315] [Reference Citation Analysis]
2 Pagani K, Lukac D, Bhukhan A, McGee JS. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview. Am J Clin Dermatol 2022. [PMID: 35441942 DOI: 10.1007/s40257-022-00689-w] [Reference Citation Analysis]
3 Novak Kujundžić R. COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3? Int J Mol Sci 2022;23:4309. [PMID: 35457123 DOI: 10.3390/ijms23084309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Trapani S, Rubino C, Lodi L, Resti M, Indolfi G. Erythema Nodosum in Children: A Narrative Review and a Practical Approach. Children (Basel) 2022;9:511. [PMID: 35455555 DOI: 10.3390/children9040511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Costescu Strachinaru DI, De Greef A, Marot L, Lerate V, Paridaens M. Pyoderma gangrenosum induced by transcutaneous electrical nerve stimulation: a case report with literature review. Oxford Medical Case Reports 2022;2022:omac017. [DOI: 10.1093/omcr/omac017] [Reference Citation Analysis]
6 Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
7 Rakowsky S, Papamichael K, Cheifetz AS. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology. [DOI: 10.1080/17474124.2022.2036122] [Reference Citation Analysis]
8 Zhao X, Jiang S, Chen Y, Liu J, Liu J, Shi X. Sweet's syndrome and mucosal prolapse polyps in a male patient with ulcerative colitis. BMC Gastroenterol 2021;21:478. [PMID: 34915857 DOI: 10.1186/s12876-021-02052-5] [Reference Citation Analysis]
9 Isac PNS, Popescu D, Genes TM, Badescu MC, Rezus II, Dima N, Ganceanu ARR, Rezus E, Rezus C. Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review. Journal of Interdisciplinary Medicine 2021;6:132-7. [DOI: 10.2478/jim-2021-0031] [Reference Citation Analysis]
10 Fradkov E, Sheehan J, Cushing K, Higgins PDR. Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease. Inflamm Bowel Dis 2021:izab201. [PMID: 34591972 DOI: 10.1093/ibd/izab201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Alvarez-Payares JC, Ramírez-Urrea S, Correa-Parra L, Salazar-Uribe D, Velásquez-López M. Mucocutaneous Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e17191. [PMID: 34548985 DOI: 10.7759/cureus.17191] [Reference Citation Analysis]
12 Aróstegui Aguilar J, Diago A, Carrillo Gijón R, Fernández Figueras M, Fraga J, García Herrera A, Garrido M, Idoate Gastearena MÁ, Christian Laga Á, Llamas-Velasco M, Martínez Campayo N, Monteagudo C, Onrubia J, Pérez Muñoz N, Ríos-Martín JJ, Ríos-Viñuela E, Rodríguez Peralto JL, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-Briz Á, Saus C, Suárez Peñaranda JM, Velasco Benito V, Beato Merino MJ, Fernandez-Flores A. Granulomas in Dermatopathology: Principal Diagnoses - Part 1. Actas Dermosifiliogr 2021:S0001-7310(21)00139-3. [PMID: 33887235 DOI: 10.1016/j.ad.2021.04.002] [Reference Citation Analysis]